Lumia Health, formerly known as STAT, is at the forefront of wearable technology innovation. Founded in 2020 and headquartered in the United States, the company is pioneering the development of the world's smallest in-ear device, designed to track drops in blood flow to the head. This technology specifically addresses health challenges associated with POTS, OH, syncope, and other dysautonomia conditions, as well as Long Covid and ME/CFS.
Operating within the AI, Hardware, and Autonomous and Sensor Tech industries, Lumia Health is setting a new standard for health and wellness optimization. Their innovative approach has attracted attention in the investment space, evidenced by a recent Non Equity Assistance investment from PharmStars on 08 December 2023. These developments suggest a promising trajectory for the company in the burgeoning wearable health tech market.